Skip to content

13F-HR filed by BOONE CAPITAL MANAGEMENT LLC

BOONE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:00:08 UTC, with 16 holding rows worth $376,702,434.

Accession
0001214659-26-014343
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 16 entries on the cover page, a total value of $376,702,434 stated on the cover page (in dollars after the unit check, H1), rows summing to $376,702,434 with VALUE read as dollars as filed, 13F file number 028-23055. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOMARIN PHARMACEUTICAL INC09061G101COM671,998$40,319,880dollars as filed
TELEFLEX INCORPORATED879369106COM288,899$36,123,931dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM415,641$35,528,993dollars as filed
UnitedHealth Group Inc91324P102COM88,687$32,555,224dollars as filed
Cigna Corporation125523100COM112,268$30,517,810dollars as filed
GUARDIAN PHARMACY SVCS INC40145W101CL A725,061$29,567,988dollars as filed
AVANTOR INC COM05352A100Stock1,838,972$27,676,529dollars as filed
LABCORP HOLDINGS INC COM SHS504922105Stock87,551$26,975,339dollars as filed
ENCOMPASS HEALTH CORP COM29261A100Stock205,838$25,007,259dollars as filed
VESTIS CORPORATION29430C102COM SHS1,583,652$21,157,591dollars as filed
PENNANT GROUP INC70805E109COM525,916$20,510,724dollars as filed
BRIDGEBIO PHARMA INC10806X102COM277,433$18,255,091dollars as filed
WAYSTAR HLDG CORP946784105COM508,649$12,889,166dollars as filed
CULLINAN THERAPEUTICS INC230031106COM690,814$10,603,995dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock179,495$4,878,674dollars as filed
Adlai Nortye00704R109SPONSORED ADS258,390$4,134,240dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-26-014343this filing2026-11-16